TFX · Teleflex Inc · Financials

$131.15 +1.47 (+1.13%)

S&P 600 member Russell 1000 member Rebalance outlook locked

Market Cap

$5.49B

42.37M

Volume · Oct 20 485.11K Avg daily vol (3M) 688.69K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Pull these statements through the financial statements API or MCP →

Revenue

$1.99B +17.2%

FY2025

Net Income

-$905.64M -1399.8%

FY2025

Gross Margin

56.24% -4.8pp

FY2025

Operating Margin

5.94% -0.2pp

FY2025

Diluted EPS

-$20.25 -1468.2%

FY2025

Operating Cash Flow

$96.68M -68%

FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow Adjusted All Metrics

Annual Quarterly

Line Item	3Y	5Y	10Y	FY2026 (G)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009	FY2008
Revenue	-10.6%	-4.7%	+1.0%	—	$2.25B	$1.99B^G	$1.7B	$1.71B	$2.79B	$2.81B^G	$2.54B	$2.6B	$2.45B	$2.15B	$1.87B	$1.81B	$1.84B	$1.7B	$1.55B	$1.49B	$1.4B	$1.43B	$1.91B
Cost of Revenue	-11.5%	-6.4%	+0.1%	—	$1.02B	$871.96M	$662.16M	$672.33M	$1.26B	$1.26B	$1.21B	$1.19B	$1.15B	$974.5M	$871.83M	$865.29M	$897.4M	$857.33M	$802.78M	$783.75M	$718.88M	$749.34M	$1.11B
Gross Profit	-9.9%	-3.3%	+1.7%	—	$1.24B	$1.12B	$1.04B	$1.04B	$1.53B	$1.55B	$1.32B	$1.41B	$1.3B	$1.17B	$996.2M	$944.4M	$942.43M	$838.95M	$748.23M	$708.78M	$678.84M	$685.54M	$801.52M
Gross Margin	—	—	—	—	—	56.24%	61.04%	60.74%	54.86%	55.15%	52.22%	54.29%	53.21%	54.6%	53.33%	52.19%	51.22%	49.46%	48.24%	47.49%	48.57%	47.78%	41.92%
Research & Development	-2.0%	+3.9%	+10.8%	—	$182.51M	$144.78M	$109.02M	$113.63M	$153.82M	$130.84M	$119.75M	$113.86M	$106.21M	$84.77M	$58.58M	$52.12M	$61.04M	$65.05M	$56.28M	$48.71M	$42.38M	$36.69M	$32.6M
Selling, General & Administrative	-5.9%	-0.6%	+2.4%	—	$869.28M	$720.17M	$674.52M	$622.74M	$863.75M	$860.09M	$743.57M	$851.77M	$797.06M	$699.96M	$563.31M	$568.98M	$578.66M	$502.19M	$454.49M	$423.91M	$403.64M	$388.28M	$502.56M
Amortization of Intangibles	-9.5%	-5.2%	+6.9%	—	$138.93M	$121.66M	$108.78M	$102.62M	$164.09M	$165.6M	$158.69M	$149.97M	$149.49M	$98.77M	$63.49M	$62.38M	$60.93M	$50.61M	$44.26M	$42.63M	$40.77M	$42.64M	$44.44M
Depreciation & Amortization	-8.3%	-4.8%	+3.6%	—	$205.79M	$177.74M	$161.53M	$148.11M	$230.59M	$237.36M	$227.25M	$218.37M	$214.71M	$160.34M	$128.35M	$125.33M	$127.03M	$107.94M	$94.88M	$96.5M	$89.74M	—	—
Restructuring Charges	+9.2%	+7.4%	+12.1%	—	$38.91M	$24.49M	$9.63M	$4.22M	$18.8M	$15M	$17.1M	$15.24M	$60.12M	$14.79M	$15.87M	$7.82M	$17.87M	$27.61M	—	$461K	$2.88M	$7.03M	—
Operating Income	-38.1%	-22.5%	-9.3%	—	$44.44M	$118.37M	$103.65M	$258.73M	$499.73M	$628.1M	$423.07M	$427.25M	$321.7M	$372.28M	$319.45M	$315.89M	$284.86M	$233.26M	-$97.38M	$229.57M	$230.29M	$250.23M	$238.96M
Operating Margin	—	—	—	—	—	5.94%	6.1%	15.11%	17.9%	22.36%	16.67%	16.46%	13.14%	17.35%	17.1%	17.46%	15.48%	13.75%	-6.28%	15.38%	16.48%	17.44%	12.5%
EBITDA	-26.0%	-14.6%	-3.9%	—	$250.24M	$296.11M	$265.19M	$406.83M	$730.32M	$865.46M	$650.32M	$645.62M	$536.42M	$532.62M	$447.8M	$441.23M	$411.89M	$341.2M	-$2.49M	$326.07M	$320.03M	—	—
Interest Expense	+22.7%	+8.6%	+5.0%	—	$113.65M	$100.22M	$83.51M	$85.08M	$54.26M	$56.97M	$66.49M	$80.27M	$103.02M	$82.55M	$54.94M	$61.32M	$65.46M	$56.91M	$69.57M	$70.32M	$79.79M	$89.14M	$121.59M
Interest Income	+91.5%	+40.8%	+28.2%	—	$6.81M	$6.4M	$6.15M	$11.68M	$912K	$1.33M	$1.16M	$1.74M	$944K	$771K	$474K	$532K	$706K	$624K	$1.57M	$1.26M	$719K	$2.48M	$2.27M
Pretax Income	-62.0%	-41.5%	-20.5%	—	-$63.55M	$24.55M	$26.29M	$185.39M	$445.92M	$559.47M	$357.73M	$339.9M	$219.63M	$284.91M	$245.73M	$244.65M	$220.11M	$175.73M	-$165.37M	$145.1M	$104.59M	$163.57M	$119.64M
Income Tax	—	—	—	—	-$38.5M	-$33.98M	-$30.9M	$41.87M	$83M	$74.35M	$21.93M	-$122.08M	$23.2M	$129.65M	$8.07M	$7.84M	$28.65M	$23.55M	$16.41M	$25.78M	$16.92M	$36.98M	$37.93M
Net Income	—	—	—	—	-$1.03B	-$905.64M	$69.68M	$356.33M	$363.14M	$485.37M	$335.32M	$461.47M	$200.8M	$152.53M	$237.38M	$244.86M	$187.68M	$150.88M	-$190.06M	$323.33M	$201.09M	$302.99M	$119.77M
Net Margin	—	—	—	—	—	-45.45%	4.1%	20.81%	13.01%	17.28%	13.22%	17.78%	8.2%	7.11%	12.71%	13.53%	10.2%	8.89%	-12.25%	21.66%	14.39%	21.12%	6.26%
Comprehensive Income	+5.2%	+29.0%	+10.0%	—	—	—	—	$445.45M	$306.58M	$435.71M	$382.42M	$458.16M	$124.81M	$326.16M	$170.62M	$134.63M	$37.64M	$172.07M	-$162.75M	$215.86M	$183.33M	—	—
EPS (Basic) USD/shares	—	—	—	—	-$23.28	-$20.30	$1.49	$7.58	$7.74	$10.38	$7.21	$9.99	$4.39	$3.39	$5.48	$5.89	$4.54	$3.67	-$4.65	$7.98	$5.04	$7.63	$3.03
EPS (Diluted) USD/shares	—	—	—	$6.90 – $7.20*	-$23.29	-$20.25^G	$1.48^G	$7.53^G	$7.68^G	$10.23^G	$7.09	$9.80	$4.29	$3.27	$4.98	$5.10	$4.04	$3.45	-$4.65	$7.92	$4.99	$7.59	$3.01
Shares Outstanding (Basic Avg) shares	-1.6%	-0.8%	+0.7%	—	—	44.62M	46.84M	46.98M	46.9M	46.77M	46.49M	46.2M	45.69M	45M	43.33M	41.56M	41.37M	41.11M	40.86M	40.5M	39.91M	39.72M	39.58M
Shares Outstanding (Diluted Avg) shares	-1.9%	-1.1%	-0.7%	—	—	44.72M	47.09M	47.3M	47.31M	47.43M	47.29M	47.09M	46.8M	46.66M	47.65M	48.06M	46.47M	43.69M	40.86M	40.8M	40.28M	39.94M	39.83M

Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2008–FY2025: $500M in buybacks, $1.06B in dividends.

Debt Profile

Completed filing coverage through Jun 15, 2026

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balance	As of	Amount	Source
Current debt and lease obligations	2026-06-30	USD 87,500,000	10-Q filed 2026-08-06
Long-term debt, including current maturities	2026-06-30	USD 2,808,009,000	10-Q filed 2026-08-06
Related accounting measures — not additional borrowing Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year. Current portion of long-term debt USD 87,500,000 Noncurrent debt carrying amount USD 2,720,509,000
Noncurrent operating lease liabilities	2026-06-30	USD 174,899,000	10-Q filed 2026-08-06

Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

5.875% senior notes due January 2032

Note · Teleflex Incorporated

Reference: 5.875% senior notes due January 2032

Active

Original principal: USD 500,000,000
Outstanding: —
Commitment: —
Availability: —
Maturity: Jan 15, 2032

Last reported interest terms: 5.875% Reported 2026-06-15 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history

Issuance · 8-K · 2026-06-15 — 8-K

Issuance · 2026-06-15 Original principal USD 500,000,000 Exact source document Parent 8-K filing · 2026-06-15
On June 15, 2026, Teleflex Incorporated (the “Company”) issued $500,000,000 aggregate principal amount of 5.875% senior notes due January 2032 (the “Notes”), pursuant to an indenture, dated as of June 15, 2026 (the “Indenture”), among the Company, the guarantors party thereto (the “Guarantors”) and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”).

Issuer evidence: On June 15, 2026, Teleflex Incorporated (the “Company”) issued $500,000,000 aggregate principal amount of 5.875% senior notes due January 2032 (the “Notes”), pursuant to an indenture, dated as of June 15, 2026 (the “Indenture”), among the Company, the guarantors party thereto (the “Guarantors”) and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”).

Supporting evidence: The Notes pay interest semi-annually on January 15 and July 15, commencing on January 15, 2027, at a rate of 5.875% per year, and mature on January 15, 2032.

Supporting evidence: On June 15, 2026, Teleflex Incorporated (the “Company”) issued $500,000,000 aggregate principal amount of 5.875% senior notes due January 2032 (the “Notes”), pursuant to an indenture, dated as of June 15, 2026 (the “Indenture”), among the Company, the guarantors party thereto (the “Guarantors”) and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”).

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue

3.55×

Peer median 3.07×

EV/EBIT

180.07×

Peer median 30.32×

P/E (TTM)

—

Peer median 35.15×

Peer medians compare against the 25 similar-size Medical Instruments & Supplies companies (of 51 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Americas Segment	$1,279,197,000	$1,156,946,000	$1,180,709,000	$1,926,348,000	$1,659,309,000	$1,465,035,000	$1,492,274,000	$1,351,699,000
EMEA Segment	$472,411,000	$340,255,000	$316,972,000	$558,373,000	$606,807,000	$584,859,000	$588,043,000	$603,813,000
Asia Segment	$241,105,000	$202,345,000	$214,760,000	$306,320,000	$297,766,000	$267,016,000	$294,328,000	$286,895,000
Oem	—	—	—	—	$245,681,000	$220,246,000	$220,717,000	$205,976,000

By Geography (USD)

Component	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
United States	$1,181,817,000	$1,079,343,000	$1,106,896,000	$1,786,467,000	$1,769,488,000	$1,567,144,000	$1,606,248,000	$1,449,426,000
Europe	$484,734,000	$347,899,000	$330,065,000	$622,343,000	$665,000,000	$646,577,000	$652,069,000	$671,264,000
Asia And Asia Pacific	$218,029,000	$179,567,000	$187,946,000	$270,749,000	$263,022,000	$230,267,000	$241,278,000	$234,090,000
All Other	$108,133,000	$92,737,000	$87,534,000	$111,482,000	$112,053,000	$93,168,000	$95,767,000	$93,603,000

By Product & Service (USD)

Component	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Vascular Access	$917,731,000	$903,512,000	$841,114,000	$683,612,000	$700,240,000	$657,703,000	$600,874,000	$575,327,000
Interventional	$647,792,000	$397,340,000	$407,251,000	$445,018,000	$427,500,000	$382,435,000	$427,563,000	$395,423,000
Surgical	$418,155,000	$404,869,000	$388,325,000	$392,917,000	$377,756,000	$317,200,000	$370,074,000	$358,707,000
Other	$9,035,000	-$6,175,000	$75,751,000	$285,148,000	$336,585,000	$367,257,000	$347,272,000	$366,845,000
Anesthesia	—	—	—	$388,890,000	$380,140,000	$302,293,000	$338,413,000	$349,370,000
Interventional Urology	—	—	—	$322,832,000	$341,661,000	$290,022,000	$290,449,000	$196,735,000
Oem	—	—	—	$272,624,000	$245,681,000	$220,246,000	$220,717,000	$205,976,000

Key facts CIK 96943 CUSIP 879369106 13F (30d) 41 filings 39 filers Visit website Investor relations